Wildlife Health Global Market Report 2025

Wildlife health encompasses the physical, behavioral, and social well-being of an animal, considering its individual, population, and broader ecosystem levels, along with its capacity to adapt to change. It involves addressing the diverse stressors affecting wildlife.

The primary categories of wildlife health include mammals, birds, fish, reptiles, and amphibians. Mammals denote members of the vertebrate animal family whose offspring are nourished by the mother's milk from specific mammary glands. The products comprise medicine, equipment, and consumables, utilizing various routes of administration such as oral, injectable, and others. The end users encompass zoos, wildlife sanctuaries, wildlife rescue and rehabilitation centers, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The wildlife health market research report is one of a series of new reports from The Business Research Company that provides wildlife health market statistics, including wildlife health industry global market size, regional shares, competitors with a wildlife health market share, detailed wildlife health market segments, market trends and opportunities, and any further data you may need to thrive in the wildlife health industry. This wildlife health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wildlife health market size has grown rapidly in recent years. It will grow from $2.49 billion in 2024 to $2.74 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to habitat destruction, availability of wildlife veterinary care facilities, advanced technologies in delivering medicines for animals in sanctuaries/zoos, increasing government initiatives to prevent zoonotic diseases from wild reservoirs.

The wildlife health market size is expected to see rapid growth in the next few years. It will grow to $4.07 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to surging demand for various animal health products, regional prospects, growing demand for companion animal health products, strategic moves by industry leaders, increasing demand for veterinary software. Major trends in the forecast period include global collaboration in disease surveillance, data analytics and artificial intelligence, growing number of wildlife conservation measures, programs and funding activities.

The forecast of 10.4% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on tracking devices, health monitoring tools, and specialized treatments may challenge conservation efforts and veterinary care for wildlife species. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in the incidence of zoonotic diseases is expected to drive the growth of the wildlife health market in the future. A zoonotic disease refers to any illness or infection that can be transmitted between animals and humans. The increase in zoonotic diseases will support the advancement and development of various health-related products for wildlife health. For example, in December 2023, the European Food Safety Authority (EFSA), an Italy-based government agency, reported that in 2022, campylobacteriosis and salmonellosis were the two most commonly reported zoonoses in humans, with 137,107 and 65,208 cases, respectively. Campylobacteriosis experienced a slight decline of 210 cases, while salmonellosis saw an increase of 5,039 cases. Nevertheless, the incidence rates per 100,000 inhabitants remained stable at 43.1 for campylobacteriosis and 15.3 for salmonellosis, in line with 2021 levels. Thus, the rise in zoonotic disease incidence is propelling the growth of the wildlife health market.

The growth of the wildlife health market is also anticipated to be fueled by wildlife conservation measures and funding activities. Wildlife conservation involves a range of strategies aimed at preserving biodiversity, requiring substantial funding for habitat restoration, anti-poaching efforts, research initiatives, and community engagement. The wildlife health market plays a crucial role in supporting these efforts by providing essential services, diagnostics, and treatments that contribute to the overall well-being of wildlife populations. For instance, in September 2023, the United States Department of the Interior allocated over $40.6 million in grants to 10 states and the U.S. through the U.S. Fish and Wildlife Service, supporting habitat acquisition and protection. Therefore, wildlife conservation measures and funding activities are driving the growth of the wildlife health market.

Technological advancements are a significant trend gaining traction in the wildlife health market. Major companies within this market are embracing new technologies to maintain their competitive edge. For example, in February 2023, the U.S. Department of Agriculture (USDA), a federal agency in the U.S., introduced new tests to track and detect COVID variants in both wild and domestic animals. These tools assist in managing the spread of zoonotic diseases. The USDA Animal and Plant Health Inspection Service (APHIS) is implementing a $300 million provision from the American Rescue Plan Act to monitor and surveil susceptible animals for the COVID virus. Through this initiative, the Agricultural Research Service (ARS), in collaboration with APHIS, is conducting five research projects to enhance understanding of the virus and help APHIS achieve its goal of establishing an early warning system to potentially prevent or mitigate future zoonotic disease outbreaks or global pandemics.

Strategic partnerships are a notable approach adopted by major companies in the wildlife health market to enhance pathogen control in equine environments. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits. In May 2023, the United States Equestrian Federation partnered with Merck Animal Health and ByoPlanet to integrate ByoPlanet's advanced technology with Merck Animal Health's antimicrobial solutions. This collaboration offers a comprehensive approach to enhancing pathogen control in equine environments, addressing wildlife health challenges proactively and introducing innovative products to positively impact the broader wildlife health market, particularly in the equine sector.

In June 2022, Zoetis Inc., a U.S.-based pharmaceutical company, acquired Basepaws for an undisclosed amount. The acquisition of Basepaws is expected to strengthen Zoetis Inc.'s presence in the precision animal health sector and guide future advancements in pet care. Basepaws, a U.S.-based company, specializes in offering DNA tests for cats and dogs.

Major companies operating in the wildlife health market include Bayer AG, Novartis AG, Merck & Co Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Genia USA Inc., Orion Corporation, Virbac Group, Royal Canin, Ceva Sante Animale Group, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Huvepharma, Vetoquinol, Indian Immunologicals Limited, Norbrook Laboratories Limited, Heska Corporation, Biogenesis Bago, Animalcare Group plc, Pneu-Dart Inc., PetAg Inc.

North America was the largest region in the wildlife health market in 2024. The regions covered in the wildlife health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the wildlife health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The wildlife health market consists of sales of immobilizing drugs, pharmaceutical drugs, and vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wildlife Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wildlife health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wildlife health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wildlife health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Animal Type: Mammals; Birds; Fish; Reptiles; Amphibians
• 2) By Product: Medicine; Equipment And Consumables
• 3) By Route Of Administration: Oral; Injectable; Other Routes Of Administration
• 4) By End-User: Zoos; Wildlife Sanctuaries; Wildlife Rescue And Rehab Centers; Other End Users
• Subsegments:
• 1) By Mammals: Large Mammals; Small Mammals
• 2) By Birds: Raptors; Waterfowl; Songbirds
• 3) By Fish: Freshwater Fish; Saltwater Fish
• 4) By Reptiles: Snakes; Lizards; Turtles And Tortoises
• 5) By Amphibians: Frogs; Salamanders; Newts
• Companies Mentioned: Bayer AG; Novartis AG; Merck & Co Inc.; Boehringer Ingelheim International GmbH; Elanco Animal Health Incorporated; IDEXX Laboratories Inc.; Genia USA Inc.; Orion Corporation; Virbac Group; Royal Canin; Ceva Sante Animale Group; Phibro Animal Health Corporation; Dechra Pharmaceuticals PLC; Huvepharma; Vetoquinol; Indian Immunologicals Limited; Norbrook Laboratories Limited; Heska Corporation; Biogenesis Bago; Animalcare Group plc; Pneu-Dart Inc.; PetAg Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.